Late-Stage TBADT-Catalyzed Oxidation Guides Structural Modification to Improve Half-Life

Please copy the URL and add it into your RSS Feed Reader.

Facebook X Linkedin Weibo

Download PDF

Synfacts 2024; 20(04): 0426
DOI: 10.1055/s-0043-1763682

Innovative Drug Discovery and Development

Contributor(s):

Antonia F. Stepan (Roche)

,

Thomas R. Puleo (Pfizer)

metabolic profiling - TBADT - BET inhibitor - C–H functionalization

Article published online:
13 March 2024

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany